key: cord-0742224-ldp0fcpe
authors: Winkler, Emma S.; Bailey, Adam L.; Kafai, Natasha M.; Nair, Sharmila; McCune, Broc T.; Yu, Jinsheng; Fox, Julie M.; Chen, Rita E.; Earnest, James T.; Keeler, Shamus P.; Ritter, Jon H.; Kang, Liang-I; Dort, Sarah; Robichaud, Annette; Head, Richard; Holtzman, Michael J.; Diamond, Michael S.
title: SARS-CoV-2 infection in the lungs of human ACE2 transgenic mice causes severe inflammation, immune cell infiltration, and compromised respiratory function
date: 2020-07-10
journal: bioRxiv
DOI: 10.1101/2020.07.09.196188
sha: 22b9c5f51b428433eb3220fa06073b99d32b42e6
doc_id: 742224
cord_uid: ldp0fcpe

Severe Acute Respiratory Syndrome Coronavirus -2 (SARS-CoV-2) emerged in late 2019 and has spread worldwide resulting in the Coronavirus Disease 2019 (COVID-19) pandemic. Although animal models have been evaluated for SARS-CoV-2 infection, none have recapitulated the severe lung disease phenotypes seen in hospitalized human cases. Here, we evaluate heterozygous transgenic mice expressing the human ACE2 receptor driven by the epithelial cell cytokeratin-18 gene promoter (K18-hACE2) as a model of SARS-CoV-2 infection. Intranasal inoculation of SARS-CoV-2 in K18-hACE2 mice results in high levels of viral infection in lung tissues with additional spread to other organs. Remarkably, a decline in pulmonary function, as measured by static and dynamic tests of respiratory capacity, occurs 4 days after peak viral titer and correlates with an inflammatory response marked by infiltration into the lung of monocytes, neutrophils, and activated T cells resulting in pneumonia. Cytokine profiling and RNA sequencing analysis of SARS-CoV-2-infected lung tissues show a massively upregulated innate immune response with prominent signatures of NF-kB-dependent, type I and II interferon signaling, and leukocyte activation pathways. Thus, the K18-hACE2 model of SARS-CoV-2 infection recapitulates many features of severe COVID-19 infection in humans and can be used to define the mechanistic basis of lung disease and test immune and antiviral-based countermeasures.

Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is the recently 45 emerged RNA virus responsible for the Coronavirus Disease 2019 (COVID- 19) pandemic. Clinical 46 disease is variable, ranging from asymptomatic infection to multi-organ failure and death, with a 47 case-fatality rate of ~5%. The binding of the SARS-CoV-2 spike protein to human angiotensin-I 48 converting enzyme-2 (hACE2) targets the virus to type II pneumocytes within the lung, resulting 49 in injury, inflammation, and subsequent respiratory distress 1,2 . Other COVID-19 manifestations 50 (e.g. cardiac dysfunction, coagulopathy, and gastrointestinal tract symptoms) suggest that extra-51 pulmonary sites of infection contribute to disease pathogenesis in some patients 3 . 52

The development of countermeasures that reduce COVID-19 morbidity and mortality is a 53 priority for the global research community, and animal models are essential for this effort. 54

Although several animal species used in laboratory research have been evaluated for 55 susceptibility to SARS-CoV-2 infection, none have recapitulated the severe disease seen in 56 hospitalized human cases. Hamsters, ferrets, and non-human primates develop mild to moderate 57 viral disease and recover spontaneously 4,5 . Conventional laboratory strains of mice cannot be 58 infected efficiently by SARS-CoV-2 because hACE2 but not mouse ACE2 supports SARS-CoV-59 2 binding 6,7 . Multiple strategies for introducing hACE2 into mice have been developed including 60

(1) transient introduction of hACE2 via adenoviral viral vectors 8 , (2) expression of hACE2 as a 61 transgene driven by heterologous gene promoters 9,10 , or (3) expression of hACE2 by the mouse 62

physiology over the course of SARS-CoV-2 infection in K18-hACE2 mice, we measured clinical 134 chemistry and hematological parameters from peripheral blood samples (Fig 3) . Plasma levels of 135 sodium, potassium, and chloride concentrations and the anion gap all trended slightly downward 136 at 7 dpi (Fig 3a-d) whereas plasma bicarbonate noticeably increased (Fig 3e) , possibly as a result 137 of poor gas exchange resulting from lung pathology or decreased respiratory drive. Other plasma 138 analytes including calcium, glucose, and blood urea nitrogen were unchanged (Fig 3f-h) . 139

Hematocrit and plasma hemoglobin levels increased later in the course of infection, possibly 140 because of reduced water intake and hemoconcentration (Fig 3i-j) . We also observed a modest 141 prolongation in the prothrombin time at 7 dpi that was preceded by an increase in D-dimer 142 concentrations on 2 and 4 dpi (Fig 3k-l) . 143 We next examined the impact of SARS-CoV-2 infection on pulmonary and cardiac function 144 using a treadmill stress-test to assess exercise tolerance (Fig 3m) . Compared to mock-infected 145 controls, at 4 dpi, a subset of SARS-CoV-2-infected K18-hACE2 mice began to show reduced 146 exercise tolerance, as measured by decreased distance travelled. However, by 5 dpi, all infected 147 K18-hACE2 mice had substantially reduced exercise tolerance compared to mock-infected 148 animals or their own pre-infection baseline performance (Fig 3m) . 149

To examine changes to the biophysical properties of the lung over the course of SARS-150

CoV-2 infection, we mechanically ventilated mice via tracheostomy and performed several forced-151 oscillation tests to determine various respiratory mechanics parameters (Fig 3n-w) . Infected 152 animals showed normal lung biomechanics at 2 and 4 dpi but had markedly abnormal values in 153 most parameters at 7 dpi relative to mock-infected controls. These abnormalities included 154 reduced inspiratory capacity as well as increased respiratory system resistance and elastance 155 (Fig 3n-p) . Collectively, these changes resulted in a downward deflection of the pressure-volume 156 loop (Fig 3r) with concomitant decreases in static compliance (Fig 3q) , the shape-describing K 157 parameter (Fig 3s) , and loop hysteresis (Fig 3t) , which together indicate reduced lung compliance 158 and distensibility. Further analysis using broadband forced oscillation maneuvers 15 revealed that 159 SARS-CoV-2 infected mice at 7 dpi had relatively normal Newtonian resistance (Fig 3u) , which 160 is primarily a reflection of resistance in larger conducting airways. In contrast, mice at 7 dpi had 161 marked increases in tissue damping (Fig 3v) and elastance (Fig 3w) ; these parameters measure 162 the dissipation and storage of oscillatory energy in parenchymal tissue and reflect tissue and 163 peripheral airway resistance and elastic recoil (i.e., tissue stiffness), respectively. The 164 measurements of mechanical properties of the respiratory system suggest that SARS-CoV-2 165 infection in K18-hACE2 mice predominantly causes disease in the alveoli and lung parenchyma, 166

and not in the conducting airways, which is consistent with both our histopathological analysis in 167 mice and measurements of pulmonary function in humans with viral pneumonia and respiratory 168 failure including COVID-19 16 . 169

The immune response to SARS-CoV-2 Infection in the lungs. An excessive pro-170 inflammatory host response to SARS-CoV-2 infection is hypothesized to contribute to pulmonary 171 pathology and the development of respiratory distress in some COVID-19 patients 17 . To evaluate 172 the composition of the immune cell response in SARS-CoV-2-infected K18-hACE2 mice, we 173 performed flow cytometric analysis on lung homogenates and bronchoalveolar lavage (BAL) fluid 174 at three time points after intranasal virus inoculation (Fig 4a-b, Extended Data Fig 4) . Consistent 175 with our histopathological analysis, we observed increased numbers of CD45 + immune cells in 176 the BAL beginning at 2 dpi and in the lung at 4 dpi. The cellular infiltrates at 4 and 7 dpi in the 177 lung were composed principally of myeloid cell subsets including Ly6G + neutrophils, Ly6C + 178 monocytes, and CD11b + CD11c + dendritic cells. In the BAL fluid, monocyte numbers peaked at 4 179 dpi, and levels of neutrophils and dendritic cells continued to rise through 7 dpi. Accumulation of 180 monocytes in the BAL fluid coincided with a decrease in the number of tissue-resident alveolar 181 macrophages, an observation consistent with scRNA-seq analysis of BAL fluid of patients with 182 severe COVID-19 disease 18,19 . By 7 dpi, we also observed an increase in several lymphoid cell 183 subsets in the lung including NK1.1 + natural killer cells, γδ CD3 + T cells, CD3 + CD4 + T cells, 184 CD3 + CD8 + T cells, and activated CD44 + CD3 + CD8 + T cells (Fig 4a) . 185

Extensive changes in cytokine profiles are associated with COVID-19 disease 186 progression 20-22 . Compared to the lungs of uninfected K18-hACE2 control mice, we observed 187 induction of Ifnb, Il28, Ifng, Cxcl10, Cxcl11, and Ccl2 mRNA over the first week (Fig 4c) with 188 highest expression occurring at 2 dpi for all cytokines except Ifng and Ccl2. We also measured 189 protein levels in the lungs using a multiplex assay of 44 different cytokines and chemokines (Fig  190   4d, Extended Data Fig 5) . Although mRNA expression was highest at 2 dpi, almost all up-191 regulated pro-inflammatory cytokines (IFNβ, IL-6, CXCL10, CXCL9, CCL5, CCL12, TIMP-1,  192 TNFα, and G-CSF), T cell-associated cytokines (IL-10, IFNγ, and IL-2), and myeloid cell- revealed distinct transcriptional signatures associated at 7 dpi (Fig 5a) with overlapping 207 signatures at 2 and 4 dpi. Hundreds of genes were differentially expressed at all time points 208 compared to mock-infected animals (Fig 5b) , many of these associated with IFN signaling, NF-209 kB-dependent cytokine responses, or leukocyte activation. In agreement with the PCA, only 449 210 differentially expressed genes were shared at all time points when compared to mock. In contrast, 211 1,975 unique differentially expressed genes were identified between mock to 7 dpi whereas only 212 59 and 152 genes were different between mock and 2 and 4 dpi, respectively (Fig 5c) . Gene 213 ontology analysis of the top upregulated genes at all time points showed enrichment of gene 214 clusters in cytokine-mediated signaling, type I and II IFN signaling, neutrophil activation, and 215 pathogen recognition receptor signaling (Fig 5d) . Upregulation of gene sets involved in cytokine-216 mediated signaling, neutrophil activation, cellular responses to type II IFN, and toll-like receptor 217 signaling were most pronounced at 7 dpi (Fig 5e- and Ifit3) versus 7 dpi (e.g., Ifnar1/2, Tyk2, Irf1 and certain ISGs Samhd1, Oas2, and Ifitm1). This 221 suggests a temporally distinct type I IFN response (Fig 5f) , which has been described previously 222 with IFNa and IFNb subtypes 28-30 . Alternatively, the differences in IFN and ISG signatures at early 223 and late time points could reflect differential signaling contributions of type I and III IFNs, as these 224 In this study, we found that SARS-CoV-2 infection of K18-hACE2 transgenic mice causes 231 severe pulmonary disease. After intranasal SARS-CoV-2 inoculation, K18-hACE2 mice rapidly 232 lost weight after 4 dpi and began to succumb to disease at 7 dpi. High levels of viral RNA and 233 infectious virus were detected in the lungs of infected animals at 2, 4, and 7 dpi by RT-qPCR, in 234 situ hybridization, and plaque assay. Infection was accompanied by high levels of pro- Mild disease is a feature of SARS-CoV-2 infection in naturally susceptible animals including 243 hamsters, ferrets, cats, and non-human primates 5 . This is perhaps unsurprising given that the 244 strongest risk factors for developing severe COVID-19 in humans (e.g., old age, cardiovascular 245 disease, and diabetes) are absent in many laboratory animals. Mild to moderate disease is seen 246 in many rodent models of SARS-CoV-2 infection, including those expressing hACE2 via viral 247 vectors or transgenes 8,11,12,33 . Thus, the severity of disease we observed following SARS-CoV-2 248 infection of K18-hACE2 mouse is unique. As the onset of severe clinical disease in K18-hACE2 249 mice occurs days after peak viral infection and is associated with high levels of infiltrating immune 250 cells and inflammatory mediators in the lung, immune responses likely contribute to pathogenesis. 251

The histopathological changes we observed in the infected lungs of K18-hACE2 mice 252 correlate with the impaired pulmonary function. Pneumocytes become infected early, which led 253 to recruitment of leukocytes into the pulmonary interstitium, production of proinflammatory 254 cytokines, injury to parenchymal cells, collapse of the alveolar space, and compromise of gas 255 exchange, all of which could cause the hypercapnia we observed at 7 dpi. This course is 256 remarkably consistent with human disease in which rapid early viral replication is followed by 257 inflammatory responses, which are believed to contribute to pathology, morbidity, and mortality 34 . 258

A fundamental understanding of the immunological processes that influence COVID-19 259 disease is needed to select immunomodulatory interventions that target key cell types or 260 pathways. We saw substantial immune cell accumulation in the lungs of K18-hACE2 mice, an The role of type I IFN in SARS-CoV-2 pathogenesis in this model warrants further 275 investigation, as it has been suggested that a dysregulated type I IFN response contributes to 276 excessive immunopathology. Indeed, in SARS-CoV infection, type I IFN signaling appears pro-277 inflammatory and not antiviral 37 . Our RNA sequencing analysis revealed differences in the type I 278 IFN gene signatures associated with early and late SARS-CoV-2 infection. Given that ISGs can 279 exert diverse functions apart from their antiviral activities, including inflammatory, metabolic, and 280 transcriptional effects 38 , these two "early" and "late" ISG modules may have different functional 281 consequences following SARS-CoV-2 infection. Furthermore, how these temporally distinct 282 programs are induced and regulated remains uncertain and may be the result of cell-type 283 specificity, kinetics, and sensitivity to different type I or III IFN subtypes. 284

The development of severe disease following SARS-CoV-2 infection is an important 285 feature of the K18-hACE2 model, although the precise reason for this susceptibility compared to 286 other hACE2 transgenic models remains unknown. Potential explanations include a high number 287 of hACE2 transgene insertions (https://www.jax.org/strain/034860) and/or the strength and 288 cellular specificity of the K18 promoter. Human ACE2 is expressed in multiple tissues in the K18-289 hACE2 mouse 9 , which could allow for SARS-CoV-2 infection of multiple organs. While we 290 detected viral RNA in several tissues, the lung was the most heavily infected and showed the 291 most consistent and severe histopathological changes; these findings were anticipated given the 292 known tropism of SARS-CoV-2 for the respiratory tract and the intranasal route of infection. 293

Moderate levels of viral RNA also were found in the heart, kidney, and spleen, with peak titers at 294 2 and 4 dpi, whereas levels in gastrointestinal tract tissues (duodenum, ileum, and colon) were 295 lower. In the gastrointestinal tract of K18-hACE2 mice, hACE2 was expressed most abundantly 296 in the colon, which correlated with infection seen at later time points. Although hACE2 is 297 expressed in the gastrointestinal tract in other hACE2-expressing mice, productive infection was 298 observed only upon intragastric inoculation or at early time points following intranasal 299 infection 11,12 . 300

We observed dichotomous SARS-CoV-2 infection in the brain, with high virus levels in 301 approximately 40% of mice at 7 dpi, and low levels in the remaining 60% of animals. Infection of 302 the brain also was observed in K18-hACE2 mice infected with SARS-CoV 9,14 but occurred earlier 303 (at 3 to 4 dpi) and more uniformly. Similar to the experiments with SARS-CoV, we did not detect 304 SARS-CoV-2 in the olfactory bulb, which suggests that both SARS-CoV and SARS-CoV-2 cross 305 the blood-brain barrier instead of traversing the cribriform plate and infecting neuronal processes 306 near the site of intranasal inoculation 39 . Notwithstanding this data, and unlike SARS-CoV, 307 alterations in smell and taste are features of SARS-CoV-2 infection in humans 40 , suggesting that 308 cell types within the olfactory system may be susceptible to infection or injury. More study is 309 needed to clarify the routes SARS-CoV-2 dissemination throughout the host and particularly how 310 it accesses the brain in some animals and humans. 311

While SARS-CoV-2 lung infection in K18-hACE2 mice provides a model for studying 312 severe infection that recapitulates features of COVID-19 in humans, we acknowledge several 313

limitations. The expression of the hACE2 transgene is non-physiological in several respects. It is 314 driven by a non-native (i.e., the cytokeratin-18) promotor, resulting in tissue expression levels that 315 are distinct from endogenously-expressed ACE2. ACE2 expression in K18-hACE2 mice is 316 independent of the complex regulatory systems that governs ACE2 levels 41 . As such, comorbid 317 conditions (e.g., obesity, hypertension, diabetes) that alter ACE2 expression in humans 41 likely 318 cannot be modelled faithfully in this transgenic mouse. 319

In summary, we found that SARS-CoV-2 infection of K18-hACE2 transgenic mice supports 320 robust viral replication in the lung, which leads to severe immune cell infiltration, inflammation, For each cytokine, fold-change was calculated compared to mock-infected animals and Log2(fold-406 change) was plotted in the corresponding heat-map (two experiments, n = 9-11 per group, 407 associated statistics are reported in Extended Data Fig 5) . 408 RNA analysis. The right lung then was inflated with ~1.2 mL of 10% neutral buffered formalin 537 using a 3-mL syringe and catheter inserted into the trachea. For harvesting of brains for fixation, 538 the mouse was decapitated, and the skull cap removed. The whole brain was removed intact, cut 539 mid-sagittally to increase surface area of fixation, and drop fixed in 10% neutral-buffered formalin 540 (NBF). For kidney, spleen, liver, and heart, organs were removed and drop-fixed in 10% NBF. For 541 fixation after infection, organs were kept in a 40-mL suspension of NBF for 7 days before further 542 processing. Tissues were embedded in paraffin, and sections were stained with hematoxylin and 543 eosin. RNA in situ hybridization was performed using the RNAscope 2.5 HD Assay (Brown Kit) 544

according to the manufacturer's instructions (Advanced Cell Diagnostics). Briefly, sections were 545 deparaffinized, treated with H 2 O 2 and Protease Plus prior to probe hybridization. Probes 546 specifically targeting hACE2 (cat no. 848151) or SARS-CoV-2 S sequence (cat no 848561) were 547 hybridized followed by proprietary signal amplification and detection with 3,3'-Diaminobenzidine. 548

Tissues were counterstained with Gill's hematoxylin. An uninfected mouse was used as a 549 negative control and stained in parallel. Tissue sections were visualized using a Nikon Eclipse 550 microscope equipped with an Olympus DP71 camera, a Leica DM6B microscope equipped with 551 a Leica DFC7000T camera, or an Olympus BX51 microscope with attached camera. 552 Clinical laboratory analysis. Testing was performed on fresh whole-blood samples 573 within a biosafety cabinet using point-of-care instruments. Prothrombin time was measured using 574 the Coagucheck (Roche) meter. Electrolyte, acid-base, and hematology parameters were 575 assayed on lithium-heparinized whole blood using the iSTAT-1 (Abbot) with the Chem8+ 576 cartridge. 577

Respiratory mechanics. Mice were anesthetized with ketamine/xylazine (100 mg/kg and 578 10 mg/kg, i.p., respectively). The trachea was isolated via dissection of the neck area and 579 cannulated using an 18-gauge blunt metal cannula (typical resistance of 0.18 cmH 2 O.s/mL), which 580 was secured in place with a nylon suture. The mouse then was connected to the flexiVent 581 computer-controlled piston ventilator (SCIREQ Inc.) via the cannula, which was attached to the 582 FX adaptor Y-tubing. Mechanical ventilation was initiated, and mice were given an additional 100 583 mg/kg of ketamine and 0.1 mg/mouse of the paralytic pancuronium bromide via intraperitoneal 584 route to prevent breathing efforts against the ventilator and during measurements. Mice were 585 ventilated using default settings for mice, which consisted in a positive end expiratory pressure at 586 3 cm H 2 O, a 10 mL/kg tidal volume (Vt), a respiratory rate at 150 breaths per minute (bpm), and 587 an fraction of inspired oxygen (FiO 2 ) of 0.21 (i.e., room air). Respiratory mechanics were assessed 588 using the forced oscillation technique, as previously described 43 , using the latest version of the 589 flexiVent operating software (flexiWare v8.1.3). Pressure-volume loops and measurements of 590 inspiratory capacity were also done. 591

Treadmill stress test. A six-lane mouse treadmill (Columbus Instruments, Columbus OH) 592 was placed within a biosafety cabinet within the ABSL-3 laboratory. Mice were introduced to the 593 treadmill test three times prior to infection, with each introductory session performed at 594 increasingly faster rates. In general, the treadmill was set to ramp from 0 to maximum speed over 595 the course of the first minute, then maintain maximum speed for 5 min. Failure to maintain 596 adequate speed resulted in delivery of a shock; this occurred until the animal reinguaged the 597 treadmill for a maximum of 5 failures. For each sex, we identified a speed at which >80% of mice 598 successfully completed the test prior to infection (16 m/s for female; 14 m/s for male). 599 RNA sequencing. cDNA libraries were constructed starting with 10 ng of total RNA from 600 lung tissues of each sample that was extracted using a MagMax mirVana Total RNA isolation kit 601 (Thermo Scientific). cDNA was generated using the Seqplex kit (Sigma-Aldrich) with amplification 602 of 20 cycles. Library construction was performed using 100 ng of cDNA undergoing end repair, A 603 tailing, ligation of universal TruSeq adapters and amplification of 8 cycles to incorporate unique 604 dual index sequences. Libraries were sequenced on the NovaSeq 6000 (Illumina, San Diego, CA) 605 targeting 40 million read pairs and extending 150 cycles with paired end reads. RNA-seq reads 606 were aligned to the mouse Ensembl GRCh38.76 primary assembly and SARS-CoV-2 NCBI 607 NC_045512 Wuhan-Hu-1 genome with STAR program (version 2.5.1a) 44 . Gene counts were 608 derived from the number of uniquely aligned unambiguous reads by Subread:featureCount 609 (version 1.4.6-p5) 45 . The ribosomal fraction, known junction saturation, and read distribution over 610 known gene models were quantified with RSeQC (version 2.6.2) 46 . All gene counts were 611 preprocessed with the R package EdgeR 47 to adjust samples for differences in library size using 612 the trimmed mean of M values (TMM) normalization procedure. Ribosomal genes and genes not 613 expressed at a level greater than or equal to 1 count per million reads in the smallest group size 614 were excluded from further analysis. The R package limma 48 with voomWithQualityWeights 615 function 49 was utilized to calculate the weighted likelihoods for all samples, based on the observed 616 mean-variance relationship of every gene and sample. Differentially expressed genes were 617 defined as those with at least 2-fold difference between two individual groups at the Benjamini-618

Hochberg false-discovery rate (FDR) adjusted p-value, i.e. q-value < 0.05. 619

Statistical analysis Statistical significance was assigned when P values were < 0.05 620 using Prism Version 8 (GraphPad) and specific tests are indicated in the Figure legends. Analysis 621 of weight change was determined by two-way ANOVA. Changes in functional parameters or 622 immune parameters were compared to mock-infected animals and were analyzed by one-way 623 ANOVA or one-way ANOVA with Dunnett's test. 624

Data availability. All data supporting the findings of this study are found within the paper 625 and its Extended Data Figures, and are available from the corresponding author upon request. 626 RNA sequencing data sets generated in this study are available at GEO: GSE154104. 627 628

SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in 630

Tissue distribution of ACE2 protein, the functional receptor for SARS 634 coronavirus. A first step in understanding SARS pathogenesis

Extra-respiratory manifestations 638 of COVID-19

Comparative pathogenesis of COVID-19, MERS, and SARS in a 642 nonhuman primate model

Animal models of mechanisms of SARS-CoV-2 infection and COVID-646 19 pathology

Functional assessment of cell entry and receptor usage 649 for SARS-CoV-2 and other lineage B betacoronaviruses

Receptor recognition by novel 653 coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS

A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by 657 Neutralizing Antibodies

Lethal infection of K18-hACE2 mice infected with severe acute 660 respiratory syndrome coronavirus

Pathogenesis of SARS-CoV-2 in Transgenic Mice Expressing Human 663

The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice

A Mouse Model of SARS-CoV-2 Infection and Pathogenesis

Engineering adolescence: maturation of human 672 pluripotent stem cell-derived cardiomyocytes

Severe acute 676 respiratory syndrome coronavirus infection causes neuronal death in the absence of 677 encephalitis in mice transgenic for human ACE2

Comparative study of 681 three flexiVent system configurations using mechanical test loads. Experimental lung 682 research 41

SARS-CoV-2-induced Acute Respiratory Distress Syndrome: Pulmonary 685 Mechanics and Gas Exchange Abnormalities. Annals of the

Complex Immune Dysregulation in COVID-19 Patients 689 with Severe Respiratory Failure

Single-cell landscape of bronchoalveolar immune cells in patients with 693 COVID-19

Host-Viral Infection Maps Reveal Signatures of Severe COVID-19 Patients

COVID-19: consider cytokine storm syndromes and immunosuppression

Clinical features of patients infected with 2019 novel coronavirus in 702

COVID-19 severity correlates with airway epithelium-immune cell 705 interactions identified by single-cell analysis

Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely correlated 709 with drastically elevated interleukin 6 (IL-6) level in critically ill COVID-19 patients

Longitudinal characteristics of lymphocyte responses and cytokine profiles in 713 the peripheral blood of SARS-CoV-2 infected patients

Plasma IP-10 and MCP-3 levels are highly associated with disease severity 717 and predict the progression of COVID-19

Heightened Innate Immune Responses in the Respiratory Tract

Imbalanced Host Response to SARS-CoV-2 Drives Development 725 of COVID-19

Distinct Roles of Interferon Alpha and Beta in Controlling Chikungunya 727

Virus Replication and Modulating Neutrophil-Mediated Inflammation

Alpha and Beta Type 1 Interferon 731 Signaling: Passage for Diverse Biologic Outcomes

Blockade of interferon Beta, but not interferon alpha, signaling controls 735 persistent viral infection

Type I and Type III Interferons -Induction, Signaling, Evasion, and 739 Application to Combat COVID-19

Shared and Distinct Functions of Type 743 I and Type III Interferons

Identification of three interferon-inducible cellular enzymes that inhibit the 747 replication of hepatitis C virus

Time Course of Lung Changes at Chest CT during Recovery from 750 Coronavirus Disease 2019 (COVID-19)

Pathological findings of COVID-19 associated with acute respiratory distress 754 syndrome. The Lancet

Clinical and immunological features of severe and moderate coronavirus 758 disease 2019

Dysregulated Type I Interferon and Inflammatory Monocyte-761

Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice

Parsing the Interferon Transcriptional Network and Its Disease 765 Associations

Two neurotropic viruses, herpes simplex virus 768 type 1 and mouse hepatitis virus, spread along different neural pathways from the main 769 olfactory bulb

Alterations in Smell or Taste in Mildly Symptomatic Outpatients With 772 SARS-CoV-2 Infection

Physiological and pathological regulation of ACE2, 775 the SARS-CoV-2 receptor

Enhancing dengue virus maturation using a stable furin over-779 expressing cell line

782 Evaluation of respiratory system mechanics in mice using the forced oscillation technique

STAR: ultrafast universal RNA-seq aligner

featureCounts: an efficient general purpose program for 789 assigning sequence reads to genomic features

RSeQC: quality control of RNA-seq experiments

edgeR: a Bioconductor package for 796 differential expression analysis of digital gene expression data

limma powers differential expression analyses for RNA-sequencing 800 and microarray studies

Why weight? Modelling sample and observational level variability improves 803 power in RNA-seq analyses